Viral load testing among pregnant women living with HIV in Mutare district of Manicaland province, Zimbabwe

[1] Tubiana R(2010)Factors associated with mother-to-child transmission of HIV-1 despite a maternal viral load < 500 copies/ml at delivery: a case-control study nested in the French perinatal cohort (EPF-ANRS CO1) Clin Infect Dis 50 585-596

[2] Le Chenadec J(2017)Pregnant and breastfeeding women: a priority population for HIV viral load monitoring PLoS Med 14 8-402

[3] Rouzioux C(2018)Prevalence of antiretroviral therapy treatment failure among HIV-infected pregnant women at first antenatal care: PMTCT option B+ in Malawi PLoS ONE 13 12-489

[4] Mandelbrot L(1999)Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission N Engl J Med 341 394-545

[5] Hamrene K(2013)Risks and benefits of lifelong antiretroviral treatment for pregnant and breastfeeding women: a review of the evidence for the option B+ approach Curr Opin HIV AIDS 8 474-2152

[6] Dollfus C(2001)Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads < 1000 copies/ml J Infect Dis 183 539-1725

[7] Myer L(2020)Virological suppression and clinical management in response to viremia in South African HIV treatment program: a multicenter cohort study PLoS Med 17 e1003037-1048

[8] Essajee S(2019)Persistent low-level viremia while on antiretroviral therapy is an independent risk factor for virologic failure Clin Infect Dis 69 2145-31

[9] Broyles LN(2015)No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception Clin Infect Dis 61 1715-181

[10] Watts DH(2018)Intensification of antiretroviral treatment with raltegravir for pregnant women living with HIV at high risk of vertical transmission J Virus Erad 4 61-9

[1] Tubiana R(2010)Factors associated with mother-to-child transmission of HIV-1 despite a maternal viral load < 500 copies/ml at delivery: a case-control study nested in the French perinatal cohort (EPF-ANRS CO1) Clin Infect Dis 50 585-596

[2] Le Chenadec J(2017)Pregnant and breastfeeding women: a priority population for HIV viral load monitoring PLoS Med 14 8-402

[3] Rouzioux C(2018)Prevalence of antiretroviral therapy treatment failure among HIV-infected pregnant women at first antenatal care: PMTCT option B+ in Malawi PLoS ONE 13 12-489

[4] Mandelbrot L(1999)Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission N Engl J Med 341 394-545

[5] Hamrene K(2013)Risks and benefits of lifelong antiretroviral treatment for pregnant and breastfeeding women: a review of the evidence for the option B+ approach Curr Opin HIV AIDS 8 474-2152

[6] Dollfus C(2001)Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads < 1000 copies/ml J Infect Dis 183 539-1725

[7] Myer L(2020)Virological suppression and clinical management in response to viremia in South African HIV treatment program: a multicenter cohort study PLoS Med 17 e1003037-1048

[8] Essajee S(2019)Persistent low-level viremia while on antiretroviral therapy is an independent risk factor for virologic failure Clin Infect Dis 69 2145-31

[9] Broyles LN(2015)No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception Clin Infect Dis 61 1715-181

[10] Watts DH(2018)Intensification of antiretroviral treatment with raltegravir for pregnant women living with HIV at high risk of vertical transmission J Virus Erad 4 61-9